Product Code: ETC5306073 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The pneumonia vaccine market in Greece is seeing growth due to increasing awareness of respiratory diseases and the importance of vaccination. The market is expanding with rising demand for vaccines to protect against pneumonia, particularly in vulnerable populations like the elderly and young children.
The pneumonia vaccine market in Greece is expanding as awareness of the importance of vaccination against respiratory diseases rises. With an aging population and increasing healthcare initiatives to prevent pneumonia, the market is experiencing growth in both pediatric and adult vaccine segments.
The Greece Pneumonia Vaccine Market is impacted by challenges related to public health policy, vaccine distribution, and cost accessibility. The market faces growing competition from a range of pneumonia vaccines, as several pharmaceutical companies develop new formulations to meet the demand for greater protection against bacterial and viral pneumonia. Additionally, the rising cost of vaccine production and distribution is a barrier for widespread adoption, particularly in the public sector. The challenge is compounded by changing healthcare regulations and the need for vaccines to remain effective against evolving strains of pneumonia.
The Greek government promotes the pneumonia vaccine market through healthcare policies focused on public health, vaccination programs, and the prevention of respiratory diseases. EU and national health regulations support the distribution and use of vaccines, contributing to a growing market for pneumonia prevention.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Pneumonia Vaccine Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Greece Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Greece Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Greece Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Greece Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 Greece Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Greece Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Greece |
4.2.2 Rising prevalence of pneumonia in the country |
4.2.3 Government initiatives to promote vaccination programs |
4.3 Market Restraints |
4.3.1 High cost associated with pneumonia vaccines |
4.3.2 Limited access to healthcare services in certain regions of Greece |
4.3.3 Vaccine hesitancy among a portion of the population |
5 Greece Pneumonia Vaccine Market Trends |
6 Greece Pneumonia Vaccine Market Segmentations |
6.1 Greece Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Greece Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.3 Greece Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 Greece Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Greece Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 Greece Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 Greece Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 Greece Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Greece Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 Greece Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 Greece Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Greece Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 Greece Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 Greece Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 Greece Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Greece Pneumonia Vaccine Market Export to Major Countries |
7.2 Greece Pneumonia Vaccine Market Imports from Major Countries |
8 Greece Pneumonia Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rate in Greece |
8.2 Number of pneumonia cases prevented through vaccination |
8.3 Percentage of infants and elderly population vaccinated |
8.4 Rate of adherence to national vaccination guidelines |
8.5 Number of healthcare facilities providing pneumonia vaccination services |
9 Greece Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Greece Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Greece Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Greece Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 Greece Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Greece Pneumonia Vaccine Market - Competitive Landscape |
10.1 Greece Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Greece Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |